Cardinal Health, Inc. (CAH) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Cardinal Health financial statements at a glance

Cardinal Health reported revenue of $254.25 billion for fiscal year 2026 (ended June 30, 2026), up 14.2% from fiscal year 2025. Net income was $1.71 billion, a net margin of 0.7%, and diluted earnings per share were $7.23.

At the end of fiscal year 2026 it had total assets of $57.30 billion, total liabilities of $60.02 billion and shareholders' equity of -$2.88 billion, with cash and short-term investments of $4.86 billion and total debt of $8.89 billion.

Its operations brought in $5.17 billion of cash; capital spending was $649.00 million, leaving free cash flow of $4.53 billion.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended June 30, 2026.

CAH logo

Cardinal Health, Inc.

CAHUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
254.25B
Prev Year: 222.58B
YoY: +14.2%
Operating Revenue
254.25B
Prev Year: 222.58B
YoY: +14.2%
Total Unusual Items Excluding Goodwill
-682.00M
Prev Year: -47.00M
YoY: -1351.1%
Total Unusual Items
-682.00M
Prev Year: -47.00M
YoY: -1351.1%
Normalized EBITDA
4.16B
Prev Year: 3.15B
YoY: +31.9%
Tax Rate for Calcs
0.216
Prev Year: 0.253
YoY: -14.7%
Tax Effect of Unusual Items
-147.13M
Prev Year: -11.89M
YoY: -1137.3%
Write-offs
299.00M
Prev Year: 18.00M
YoY: +1561.1%
Depreciation Amortization Depletion
469.00M
Prev Year: 464.00M
YoY: +1.1%
Depreciation and amortization
469.00M
Prev Year: 464.00M
YoY: +1.1%
Amortization
469.00M
Prev Year: 464.00M
YoY: +1.1%
Amortization of Intangibles
469.00M
Prev Year: 464.00M
YoY: +1.1%
Cost of Revenue
244.47B
Prev Year: 214.41B
YoY: +14.0%
Gross Profit
9.77B
Prev Year: 8.17B
YoY: +19.7%
Operating Expense
6.60B
Prev Year: 5.85B
YoY: +12.9%
Selling General and Administrative
6.13B
Prev Year: 5.38B
YoY: +13.9%
Operating Income
3.17B
Prev Year: 2.32B
YoY: +36.6%
Net Non Operating Interest Income Expense
-348.00M
Prev Year: -215.00M
YoY: -61.9%
Non-operating Interest Expense
348.00M
Prev Year: 215.00M
YoY: +61.9%
Other Income Expense
-651.00M
Prev Year: -6.00M
YoY: -10750.0%
Special Income Charges
-682.00M
Prev Year: -47.00M
YoY: -1351.1%
Equity in Earnings of Affiliates
-
Restructuring and Mergers Acquisition
393.00M
Prev Year: 214.00M
YoY: +83.6%
Other Special Charges
-10.00M
Prev Year: -185.00M
YoY: +94.6%
Impairment of Capital Assets
-
Other Non-operating Income (expense)
31.00M
Prev Year: 41.00M
YoY: -24.4%
Pre-tax Income
2.17B
Prev Year: 2.10B
YoY: +3.5%
Provision for Income Taxes
469.00M
Prev Year: 532.00M
YoY: -11.8%
Net Income Common Stockholders
1.71B
Prev Year: 1.56B
YoY: +9.8%
Net Income
1.71B
Prev Year: 1.56B
YoY: +9.8%
Net Income Including Non-Controlling Interests
1.71B
Prev Year: 1.57B
YoY: +8.7%
Net Income from Continuing Operations
1.71B
Prev Year: 1.57B
YoY: +8.7%
Noncontrolling Interests
9.00M
Prev Year: -8.00M
YoY: +212.5%
Diluted NI Available to Com Stockholders
1.71B
Prev Year: 1.56B
YoY: +9.8%
Basic EPS
7.27
Prev Year: 6.48
YoY: +12.2%
Diluted EPS
7.23
Prev Year: 6.45
YoY: +12.1%
Weighted Average Shares (basic)
236.00M
Prev Year: 241.00M
YoY: -2.1%
Weighted Average Shares (diluted)
237.00M
Prev Year: 242.00M
YoY: -2.1%
Total Operating Income as Reported
2.61B
Prev Year: 2.27B
YoY: +14.9%
Total Expenses
251.07B
Prev Year: 220.26B
YoY: +14.0%
Net Income from Continuing and Discontinued Operation
1.71B
Prev Year: 1.56B
YoY: +9.8%
Normalized Income
2.25B
Prev Year: 1.60B
YoY: +40.9%
Interest Expense
348.00M
Prev Year: 215.00M
YoY: +61.9%
Net Interest Income
-348.00M
Prev Year: -215.00M
YoY: -61.9%
EBIT
2.52B
Prev Year: 2.32B
YoY: +8.9%
EBITDA
3.48B
Prev Year: 3.11B
YoY: +12.0%
Reconciled Cost of Revenue
243.99B
Prev Year: 214.08B
YoY: +14.0%
Reconciled Depreciation
956.00M
Prev Year: 790.00M
YoY: +21.0%
Net Income from Continuing Operation Net Minority Interest
1.71B
Prev Year: 1.56B
YoY: +9.8%
Values in USD

Cardinal Health key figures by fiscal year

FY2026FY2025FY2024FY2023FY2022
Revenue$254.2B$222.6B$226.8B$205.0B$181.3B
Gross profit$9.8B$8.2B$7.4B$6.9B$6.5B
Operating income$3.2B$2.3B$2.1B$1.8B$1.6B
Net income$1.7B$1.6B$852.0M$330.0M-$938.0M
Diluted EPS$7.23$6.45$3.45$1.00-$3.35
Total assets$57.3B$53.1B$45.1B$43.3B$43.9B
Total liabilities$60.0B$55.8B$48.3B$46.3B$44.6B
Shareholders' equity-$2.9B-$2.8B-$3.2B-$3.0B-$709.0M
Cash and short-term investments$4.9B$3.9B$5.1B$4.1B$4.7B
Total debt$8.9B$8.5B$5.1B$4.7B$5.3B
Operating cash flow$5.2B$2.4B$3.8B$2.8B$3.2B
Capital spending$649.0M$547.0M$511.0M$481.0M$387.0M
Free cash flow$4.5B$1.9B$3.3B$2.4B$2.8B

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2015.

Questions and answers

What was Cardinal Health's revenue in fiscal year 2026?

$254.25 billion, up 14.2% from $222.58 billion in fiscal year 2025.

How much profit does Cardinal Health make?

Cardinal Health reported net income of $1.71 billion for fiscal year 2026 (0.7% of revenue); operating income was $3.17 billion.

How much cash and debt does Cardinal Health have?

At the end of fiscal year 2026: cash and short-term investments of $4.86 billion and total debt of $8.89 billion.

What is Cardinal Health's free cash flow?

$4.53 billion in fiscal year 2026 (operating cash flow of $5.17 billion minus capital spending of $649.00 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube